Nilemdo® — zusätzliche Lipidsenkung bei ausgereizter Statintherapie
Crossref DOI link: https://doi.org/10.1007/s15006-020-0760-9
Published Online: 2020-08-13
Published Print: 2020-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wedekind, Silke
Text and Data Mining valid from 2020-08-01
Version of Record valid from 2020-08-01
Article History
First Online: 13 August 2020
Free to read: This content has been made available to all.